Ries LAG, Eisner MP, Kosary CL.
et al. SEER Cancer Statistics Review, 1973-1998. Bethesda, Md: National Cancer Institute, National Institutes of Health;
Marcella S, Miller JE. Racial differences in colorectal cancer mortality: the importance of
stage and socioeconomic status. J Clin Epidemiol.2001;54:359-366.
Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis
of seven selected sites. Am J Epidemiol.1991;133:672-682.
Steinhorn SC, Myers MH, Hankey BF, Pelham VF. Factors associated with survival differences between black women and
white women with cancer of the uterine corpus. Am J Epidemiol.1986;124:85-93.
Howard J, Hankey BF, Greenberg RS.
et al. A collaborative study of differences in the survival rates of black
patients and white patients with cancer. Cancer.1992;69:2349-2360.
Hill HA, Eley JW, Harlan LC.
et al. Racial differences in endometrial cancer survival: the black/white
cancer survival study. Obstet Gynecol.1996;88:919-926.
Eley JW, Hill HA, Chen VW.
et al. Racial differences in survival from breast cancer: results of the National
Cancer Institute Black/White Cancer Survival Study. JAMA.1994;272:947-954.
Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socio-economic status and access to minimum expected
therapy among female breast cancer patients in the National Cancer Institute
Black-White Cancer Survival Study. Ethn Dis.1999;9:111-125.
Chen VW, Correa P, Kurman RJ.
et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev.1994;3:127-135.
Evans LA. Black and white differences: narrowing the gap in cancer medicine. In Vivo.1992;6:429-434.
Pettaway CA. Racial differences in the androgen/androgen receptor pathway in prostate
cancer. J Natl Med Assoc.1999;91:653-660.
Carethers JM. Racial and ethnic factors in the genetic pathogenesis of colorectal
cancer. J Assoc Acad Minor Phys.1999;10:59-67.
Jetter A. Breast cancer in blacks spurs hunt for answers. New York Times.February 22, 2000;sect F:7.
Freeman HP. The meaning of race in science: considerations for cancer research. Cancer.1998;82:219-225.
Freedman LS, Simon R, Foulkes MA.
et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization
Act of 1993: the perspective of NIH clinical trials. Control Clin Trials.1995;16:277-285.
Evaluation of priority setting and programs of research on ethnic minority
and medically underserved populations at the National Institutes of Health. In: Haynes MA, Smedley BD, eds.The Unequal Burden of Cancer:
An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically
Underserved. Washington, DC: National Academy Press; 1999:154-186.
Aging, Race, and Ethnicity in Prostate Cancer . Bethesda, Md: US Dept of Health and Human Services, National Institute
on Aging; 2001. RFA publication AG-02-003.
Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst.2002;94:334-357.
Muss HB, Hunter CP, Wesley M.
et al. Treatment plans for black and white women with stage II node-positive
breast cancer. Cancer.1992;70:2460-2467.
Smith TJ, Penberthy L, Desch CE.
et al. Differences in initial treatment patterns and outcomes of lung cancer
in the elderly. Lung Cancer.1995;13:235-252.
Diehr P, Yergan J, Chu J.
et al. Treatment modality and quality differences for black and white breast-cancer
patients treated in community hospitals. Med Care.1989;27:942-958.
Lee JA, Gehlbach S, Hosmer D, Reti M, Baker CS. Medicare treatment differences for blacks and whites. Med Care.1997;35:1173-1189.
Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate
cancer. Med Care.1998;36:1337-1348.
Brawley OW, Freeman HP. Race and outcomes: is this the end of the beginning for minority health
research? J Natl Cancer Inst.1999;91:1908-1909.
Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in
an equal-access medical system. Cancer.1998;82:2312-2320.
Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med.1999;341:1198-1205.
Dignam JJ, Colangelo L, Tian W.
et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant
therapy trials: findings from the National Surgical Adjuvant Breast and Bowel
Project. J Natl Cancer Inst.1999;91:1933-1940.
Roach M. Is race an independent prognostic factor for survival from prostate
cancer? J Natl Med Assoc.1998;90:S713-S719.
Roach M, Cirrincione C, Budman D.
et al. Race and survival from breast cancer: based on Cancer and Leukemia
Group B trial 8541. Cancer J Sci Am.1997;3:107-112.
Cella DF, Orav EJ, Kornblith AB.
et al. Socioeconomic status and cancer survival. J Clin Oncol.1991;9:1500-1509.
Morgan MA, Behbakht K, Benjamin I.
et al. Racial differences in survival from gynecologic cancer. Obstet Gynecol.1996;88:914-918.
Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and
outcomes of colorectal cancer. J Natl Cancer Inst.2001;93:501-515.
West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black
and white women. Ann Epidemiol.1996;6:413-419.
Sutherland CM, Mather FJ. Long-term survival and prognostic factors in breast cancer patients
with localized (no skin, muscle, or chest wall attachment) disease with and
without positive lymph nodes. Cancer.1986;57:622-629.
Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary
breast cancer. Ann Intern Med.1994;120:104-110.
Collett D. Modelling Survival Data in Medical Research. Boca Raton, Fla: CRC Press; 1994:1.
Fowler Jr JE, Bigler SA, Bowman G, Kilambi NK. Race and cause specific survival with prostate cancer: influence of
clinical stage, Gleason score, age and treatment. J Urol.2000;163:137-142.
Fowler Jr JE, Terrell F. Survival in blacks and whites after treatment for localized prostate
cancer. J Urol.1996;156:133-136.
Manne U, Weiss HL, Grizzle WE. Racial differences in the prognostic usefulness of MUC1 and MUC2 in
colorectal adenocarcinomas. Clin Cancer Res.2000;6:4017-4025.
Manne U, Weiss HL, Grizzle WE. Bcl-2 expression is associated with improved prognosis in patients
with distal colorectal adenocarcinomas. Int J Cancer.2000;89:423-430.
Roach M, Alexander M. The prognostic significance of race and survival from breast cancer:
a model for assessing the reliability of reported survival differences. J Natl Med Assoc.1995;87:214-219.
Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published
literature for survival endpoints. Stat Med.1998;17:2815-2834.
Armstrong RJ. US Decennial Life Tables for 1989-1991. Hyattsville, Md: US Dept of Health and Human Services, National Center
for Health Statistics; 1997:13.
Ries LAG, Eisner MP, Kosary CL.
et al. SEER Cancer Statistics Review, 1973-1997. Bethesda, Md: National Cancer Institute, National Institutes of Health;
Tudur C, Williamson PR, Khan S, Best LY. The value of the aggregate data approach in meta-analysis with time-to-event
outcomes. J R Stat Soc.2001;164:357-370.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials.1986;7:177-188.
Light RJ, Pillemar DB. Summing Up: The Science of Reviewing Research. Cambridge, Mass: Harvard University Press; 1984.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication
Akerley 3rd WL, Moritz TE, Ryan LS.
et al. Racial comparison of outcomes of male Department of Veterans Affairs
patients with lung and colon cancer. Arch Intern Med.1993;153:1681-1688.
Graham MV, Geitz LM, Byhardt R.
et al. Comparison of prognostic factors and survival among black patients
and white patients treated with irradiation for non-small-cell lung cancer. J Natl Cancer Inst.1992;84:1731-1735.
Greenwald HP, Polissar NL, Borgatta EF.
et al. Social factors, treatment, and survival in early-stage non-small cell
lung cancer. Am J Public Health.1998;88:1681-1684.
Page WF, Kuntz AJ. Racial and socioeconomic factors in cancer survival. Cancer.1980;45:1029-1040.
Mayberry RM, Coates RJ, Hill HA.
et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst.1995;87:1686-1693.
Thompson I, Tangen C, Tolcher A.
et al. Association of African-American ethnic background with survival in
men with metastatic prostate cancer. J Natl Cancer Inst.2001;93:219-225.
McLeod DG, Schellhammer PF, Vogelzang NJ.
et al. Exploratory analysis on the effect of race on clinical outcome in patients
with advanced prostate cancer receiving bicalutamide or flutamide, each in
combination with LHRH analogues. Prostate.1999;40:218-224.
Roach M, Krall J, Keller JW.
et al. The prognostic significance of race and survival from prostate cancer
based on patients irradiated on Radiation Therapy Oncology Group protocols
(1976-1985). Int J Radiat Oncol Biol Phys.1992;24:441-449.
Crawford ED, Blumenstein BA, Goodman PJ.
et al. Leuprolide with and without flutamide in advanced prostate cancer. Cancer.1990;66:1039-1044.
Hart KB, Porter AT, Shamsa F.
et al. The influence of race on the efficacy of curative radiation therapy
for carcinoma of the prostate. Semin Urol Oncol.1998;16:227-231.
Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF. Carcinoma of the prostate: race as a prognostic indicator in definitive
radiation therapy. Radiology.1995;194:545-549.
Lawton CA, Cantrell JE, Derus SW.
et al. Prostate cancer: are racial differences in clinical stage and survival
explained by differences in symptoms? Radiology.1994;192:37-40.
Austin JP, Convery K. Age-race interaction in prostatic adenocarcinoma treated with external
beam irradiation. Am J Clin Oncol.1993;16:140-145.
Zagars GK, Pollack A, Pettaway CA. Prostate cancer in African-American men: outcome following radiation
therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys.1998;42:517-523.
Krongrad A, Lai H, Lamm SH, Lai S. Mortality in prostate cancer. J Urol.1996;156:1084-1091.
Optenberg SA, Thompson IM, Friedrichs P.
et al. Race, treatment, and long-term survival from prostate cancer in an
equal-access medical care delivery system. JAMA.1995;274:1599-1605.
Robbins AS, Whittemore AS, Van Den Eeden SK. Race, prostate cancer survival, and membership in a large health maintenance
organization. J Natl Cancer Inst.1998;90:986-990.
Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: does it impact on
prostate cancer at presentation and survival? Urology.1995;46:825-830.
Brawn PN, Johnson EH, Kuhl DL.
et al. Stage at presentation and survival of white and black patients with
prostate carcinoma. Cancer.1993;71:2569-2573.
Dignam JJ, Redmond CK, Fisher B.
et al. Prognosis among African-American women and white women with lymph node
negative breast carcinoma: findings from two randomized clinical trials of
the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer.1997;80:80-90.
Kimmick G, Muss HB, Case LD, Stanley V. A comparison of treatment outcomes for black patients and white patients
with metastatic breast cancer. Cancer.1991;67:2850-2854.
Heimann R, Ferguson D, Powers C.
et al. Race and clinical outcome in breast cancer in a series with long-term
follow-up evaluation. J Clin Oncol.1997;15:2329-2337.
Fields JN, Kuske RR, Perez CA.
et al. Prognostic factors in inflammatory breast cancer: univariate and multivariate
Howard DL, Penchansky R, Brown MB. Disaggregating the effects of race on breast cancer survival. Fam Med.1998;30:228-235.
Franzini L, Williams AF, Franklin J.
et al. Effects of race and socioeconomic status on survival of 1,332 black,
Hispanic, and white women with breast cancer. Ann Surg Oncol.1997;4:111-118.
Perkins P, Cooksley CD, Cox JD. Breast cancer: is ethnicity an independent prognostic factor for survival? Cancer.1996;78:1241-1247.
Pierce L, Fowble B, Solin LJ.
et al. Conservative surgery and radiation therapy in black women with early
stage breast cancer. Cancer.1992;69:2831-2841.
Roetzheim RG, Gonzalez EC, Ferrante JM.
et al. Effects of health insurance and race on breast carcinoma treatments
and outcomes. Cancer.2000;89:2202-2213.
Mancino AT, Rubio IT, Henry-Tillman R.
et al. Racial differences in breast cancer survival: the effect of residual
disease. J Surg Res.2001;100:161-165.
Yood MU, Johnson CC, Blount A.
et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst.1999;91:1487-1491.
Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women
in an equal-access health care system. Cancer.1998;82:1310-1318.
Ansell D, Whitman S, Lipton R, Cooper R. Race, income, and survival from breast cancer at two public hospitals. Cancer.1993;72:2974-2978.
Gregorio DI, Cummings KM, Michalek A. Delay, stage of disease, and survival among white and black women with
breast cancer. Am J Public Health.1983;73:590-593.
Amendola B, Hazra TA, Belgrad R, King ER. Radiation therapy for esophageal cancer: the Medical College of Virginia
experience. South Med J.1980;73:1481-1483.
Modiano MR, Villar-Werstler P, Crowley J, Salmon SE. Evaluation of race as a prognostic factor in multiple myeloma. J Clin Oncol.1996;14:974-977.
Savage D, Lindenbaum J, Van Ryzin J.
et al. Race, poverty, and survival in multiple myeloma. Cancer.1984;54:3085-3094.
Arbes SJJ, Olshan AF, Caplan DJ.
et al. Factors contributing to the poorer survival of black Americans diagnosed
with oral cancer (United States). Cancer Causes Control.1999;10:513-523.
Franco EL, Dib LL, Pinto DS.
et al. Race and gender influences on the survival of patients with mouth cancer. J Clin Epidemiol.1993;46:37-46.
Roach M, Alexander M, Coleman JL. The prognostic significance of race and survival from laryngeal carcinoma. J Natl Med Assoc.1992;84:668-674.
Hicks ML, Kim W, Abrams J.
et al. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc.1997;89:134-140.
Simpson JR, Scott CB, Rotman M.
et al. Race and prognosis of brain tumor patients entering multicenter clinical
trials. Am J Clin Oncol.1996;19:114-120.
Grigsby PW, Hall-Daniels L, Baker S, Perez CA. Comparison of clinical outcome in black and white women treated with
radiotherapy for cervical carcinoma. Gynecol Oncol.2000;79:357-361.
Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol.1999;94:509-515.
Farley JH, Hines JF, Taylor RR.
et al. Equal care ensures equal survival for African-American women with cervical
Thoms WW, Unger ER, Johnson PR.
et al. Cervical cancer survival in a high risk urban population. Cancer.1995;76:2518-2523.
Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma in the American black. Cancer.1983;52:1959-1965.
Hoyert DL, Arias E, Smith BL.
et al. Deaths: Final Data for 1999: National Vital Statistics
Report, 49(8). Hyattsville, Md: National Center for Health Statistics; 2001.
Shwartz M. Estimates of lead time and length bias in a breast cancer screening
Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques
as a source of misleading statistics for survival in cancer. N Engl J Med.1985;312:1604-1608.
Hunter CP, Redmond CK, Chen VW.
et al. Breast cancer: factors associated with stage at diagnosis in black
and white women. J Natl Cancer Inst.1993;85:1129-1137.
Moody-Ayers SY, Wells CK, Feinstein AR. Benign tumors and early detection in mammography-screened patients
of a natural cohort with breast cancer. Arch Intern Med.2000;160:1109-1115.
Breen N, Wagener DK, Brown ML.
et al. Progress in cancer screening over a decade: results of cancer screening
from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst.2001;93:1704-1713.
Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst.1993;85:979-987.
Smedley BD, Stith AY, Nelson AR.for the Committee on Understanding and Eliminating Racial and Ethnic
Disparities in Health Care, Board on Health Sciences Policy. Unequal Treatment: Confronting Racial and Ethnic
Disparities in Health Care. Washington, DC: National Academy Press; 2002.